10 November 2023 false No description of principal activity Taxfiler 2024.6 15274893business:PrivateLimitedCompanyLtd2023-11-102024-11-30 152748932023-11-09 152748932023-11-102024-11-30 15274893business:AuditExemptWithAccountantsReport2023-11-102024-11-30 15274893business:FilletedAccounts2023-11-102024-11-30 152748932024-11-30 15274893business:Director12023-11-102024-11-30 15274893business:RegisteredOffice2023-11-102024-11-30 15274893core:WithinOneYear2024-11-30 15274893core:ShareCapitalcore:PreviouslyStatedAmount2024-11-30 15274893core:PreviouslyStatedAmount2024-11-30 15274893business:SmallEntities2023-11-102024-11-30 15274893countries:EnglandWales2023-11-102024-11-30 iso4217:GBP xbrli:pure
Company Registration No. 15274893 (England and Wales)
Ab Biotech Consulting Limited Unaudited accounts for the period from 10 November 2023 to 30 November 2024
Ab Biotech Consulting Limited Unaudited accounts Contents
Page
- 2 -
Ab Biotech Consulting Limited Company Information for the period from 10 November 2023 to 30 November 2024
Director
Ashley Kim Browne
Company Number
15274893 (England and Wales)
Registered Office
222 Amesbury Avenue Flat A London SW2 3BL United Kingdom
Accountants
One Abacus Limited Coldharbour Works 245a Coldharbour Lane London SW9 8RR
- 3 -
Ab Biotech Consulting Limited Statement of financial position as at 30 November 2024
2024 
Notes
£ 
Current assets
Debtors
2,480 
Cash at bank and in hand
40,640 
43,120 
Creditors: amounts falling due within one year
(43,119)
Net current assets
1 
Net assets
1 
Capital and reserves
Called up share capital
1 
Shareholders' funds
1 
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 6 February 2025 and were signed on its behalf by
Ashley Kim Browne Director Company Registration No. 15274893
- 4 -
Ab Biotech Consulting Limited Notes to the Accounts for the period from 10 November 2023 to 30 November 2024
1
Statutory information
Ab Biotech Consulting Limited is a private company, limited by shares, registered in England and Wales, registration number 15274893. The registered office is 222 Amesbury Avenue, Flat A, London, SW2 3BL, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2024 
£ 
Amounts falling due within one year
Trade debtors
2,479 
Other debtors
1 
2,480 
5
Creditors: amounts falling due within one year
2024 
£ 
Loans from directors
2,046 
Accruals
41,073 
43,119 
6
Average number of employees
During the period the average number of employees was 0.
- 5 -